Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
30.48B | 31.39B | 27.89B | 23.85B | 18.83B | 16.14B | Gross Profit |
18.09B | 18.27B | 16.58B | 13.47B | 10.86B | 8.87B | EBIT |
1.81B | 1.66B | 1.65B | 271.00M | -594.00M | -3.34B | EBITDA |
2.16B | 2.08B | 1.94B | 772.00M | -242.00M | -3.91B | Net Income Common Stockholders |
1.43B | 1.23B | 1.40B | 276.00M | 1.91B | -4.67B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.99B | 4.24B | 4.54B | 3.94B | 4.33B | 3.67B | Total Assets |
10.29B | 11.87B | 10.85B | 9.60B | 9.81B | 9.11B | Total Debt |
700.00M | 1.60B | 1.00B | 1.65B | 2.31B | 3.91B | Net Debt |
-2.29B | -2.64B | -3.54B | -2.30B | -2.01B | 238.00M | Total Liabilities |
5.94B | 7.16B | 5.90B | 5.89B | 6.39B | 7.63B | Stockholders Equity |
4.14B | 4.48B | 4.78B | 3.59B | 3.34B | 1.40B |
Cash Flow | Free Cash Flow | ||||
0.00 | 683.00M | 1.43B | 200.00M | 2.17B | -3.21B | Operating Cash Flow |
0.00 | 2.13B | 2.23B | 726.00M | 2.35B | -2.70B | Investing Cash Flow |
0.00 | -1.49B | -787.00M | -478.00M | -160.00M | -496.00M | Financing Cash Flow |
0.00 | -1.05B | -889.00M | -773.00M | -1.59B | 4.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥29.65B | 17.04 | 2.36% | 6.21% | 32.82% | ||
70 Outperform | ¥49.48B | 33.54 | 1.20% | 4.50% | -10.16% | ||
67 Neutral | ¥38.47B | 31.39 | 0.09% | 12.52% | -5.69% | ||
67 Neutral | ¥49.99B | 53.60 | 0.62% | 12.04% | -48.52% | ||
65 Neutral | ¥41.16B | 11.54 | 0.99% | 7.79% | -5.17% | ||
62 Neutral | $6.82B | 11.05 | 2.80% | 4.32% | 2.67% | -24.92% | |
55 Neutral | ¥19.06B | 20.23 | 0.56% | 3.24% | -11.45% |